Matrix Metalloproteinases in the Hematopoietic Microenvironment

References

• Birkedal-Hansen, H., Moore, W. G. I., Bodden, M. K., Windsor, L. J., Birkedal-Hansen, B., DeCarlo, A. and Engler, J. A. (1993). Matrix metalloproteinases: a review, Crit Rev Oral Biol Med, 4, 197.
   PubMedGoogle Scholar
• Birkedal-Hansen, H. (1995). Proteolytic remodeling of extracellular matrix, Curr Opin Cell Biol, 7, 728.
   PubMed Web of Science ®Google Scholar
• Murphy, G. (1995). Matrix metalloproteinases and their inhibitors, Acta Orthop Scan (Suppl 226), 66, 55.
   Web of Science ®Google Scholar
• Murphy, G. and Knä;uper, V. (1997). Relating matrix metalloproteinase structure to function: why the “hemopexin” domain?, Matrix Biol, 15, 511.
   PubMed Web of Science ®Google Scholar
• Stetler-Stevenson, W. G., Hewitt, R. and Corcoran, M. (1996). Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic, Sem Cancer Biol, 7, 147.
   PubMed Web of Science ®Google Scholar
• Chambers, A. F. and Matrisian, L. M. (1997). Changing views of the role of matrix metalloproteinases in metastasis, J Natl Cancer Inst, 89, 1260.
   PubMed Web of Science ®Google Scholar
• Sato, H. and Seiki, M. (1996). Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis, J Biochem, 119, 209.
   PubMed Web of Science ®Google Scholar
• Stetler-Stevenson, M., Mansoor, A., Lim, M., Fukushima, P., Kehrl, J., Marti, G., Ptaszynski, K., Wang, J. and Stetler-Stevenson, W. G. (1997). Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in reactive and neoplastic lymphoid cells, Blood, 89, 1708.
   PubMed Web of Science ®Google Scholar
• Kossakowska, A. E., Urbanski, S. J., Huchcroft, S. A. and Edwards, D. R. (1992). Relationship between the clinical aggressiveness of large cell immunoblastic lymphomas and expression of 92 kDa gelatinase (type IV collagenase) and tissue inhibitor of metalloproteinase-1 (TIMP-1) RNAs, Oncol Res, 4, 233.
   PubMed Web of Science ®Google Scholar
• Matsuzaki, A. and Janowska-Wieczorek, A. (1997). Unstimulated human acute myelogenous leukemia blasts secrete matrix metalloproteinases, J Cancer Res Clin Oncol, 123, 100.
   PubMed Web of Science ®Google Scholar
• Sawicki, G., Matsuzaki, A. and Janowska-Wieczorek, A. (1998). Expression of the active form of MMP-2 on the surface of leukemic cells accounts for their in vitro invasion, J Cancer Res Clin Oncol, 124, 245.
   PubMed Web of Science ®Google Scholar
• Janowska-Wieczorek, A., Marquez, L. A., Matsuzaki, A., Hashmi, H. R., Larratt, L., Boshkov, L., Turner, A. R., Zhang, M. C., Edwards, D. R. and Kossakowska, A. E. (1999). Expression of matrix metalloproteinases (MMP-2 and -9) and tissue inhibitors of metalloproteinases (TIMP-1 and -2) in acute myelogenous leukemia blasts: comparison with normal bone marrow cells, Brit J Haematol, 105, 402.
   PubMed Web of Science ®Google Scholar
• Kossakowska, A. E., Urbanski, S. J. and Edwards, D. R. (1991). Tissue inhibitor of metalloproteinases-1 (TIMP-1) RNA is expressed at elevated levels in malignant non-Hodgkin's lymphomas, Blood, 77, 2475.
   PubMed Web of Science ®Google Scholar
• Kossakowska, A. E., Edwards, D. R., Prusinkiewicz, C., Zhang, M. C., Guo, D., Urbanski, S. J., Grogan, T., Marquez, L. A. and Janowska-Wieczorek, A. (1999). Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin's lymphomas, Blood, 94, 2080.
   PubMed Web of Science ®Google Scholar
• Werb, Z. (1997). ECM and cell surface proteolysis: regulating cellular ecology, Cell, 91, 439.
   PubMed Web of Science ®Google Scholar
• Llano, E., Pendas, A. M., Freije, J. P., Nakano, A., Knäuper, V., Murphy, G. and Lopez-Otin, C. (1999). Identification and characterization of human MT5-MMP, a new membrane-bound activator of progelatinase A overexpressed in brain tumors, Cancer Res, 59, 2570.
   PubMed Web of Science ®Google Scholar
• Cossins, J., Dudgeon, T. J., Catlin, G., Gearing, A. J. H. and Clements, J. M. (1996). Identification of MMP-18, a putative novel human matrix metalloproteinase, Biochem Biophys Res Comm, 228, 494.
   PubMed Web of Science ®Google Scholar
• Pendas, A. M., Knauper, V., Puente, X. S., Llano, E., Mattei, M.-G., Apte, S., Murphy, G. and Lopez-Otin, C. (1997). Identification and characterization of a novel human matrix metalloproteinase with unique structural characteristics, chromosomal location and tissue distribution, J Biol Chem, 272, 4281.
   PubMed Web of Science ®Google Scholar
• Van Wart, H. E. and Birkedal-Hansen, H. (1990). The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family, Proc Natl Acad Sci USA, 87, 5578.
   PubMed Web of Science ®Google Scholar
• Hasty, K. A., Pourmotabbed, T. F., Goldberg, G. I., Thompson, J. P., Spinella, D. G., Stevens, R. M. and Mainardi, C. (1994). Human neutrophil collagenase, J Biol Chem, 265, 11421.
   Google Scholar
• Stetler-Stevenson, W. G. (1994). Progelatinase A activation during tumor cell invasion, Invasion Metastasis, 14, 259.
   PubMedGoogle Scholar
• Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E. and Seiki, M. (1994). A matrix metalloproteinase expressed on the surface of invasive tumor cells, Nature, 370, 61.
   PubMed Web of Science ®Google Scholar
• Imai, K., Ohuchi, E., Aoki, T., Nomura, H., Fujii, Y., Sato, H., Seiki, M. and Okada, Y. (1996). Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinses 2, Cancer Res, 56, 2707.
   PubMed Web of Science ®Google Scholar
• Strongin, A. Y., Collier, I., Bannikov, G., Marmer, B. L., Grants, G. A. and Goldberg, G. I. (1995). Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of membrane metalloproteinase, J Biol Chem, 270, 5331.
   PubMed Web of Science ®Google Scholar
• Emmert-Buck, M. R., Emonard, H. P., Corcoran, M. L., Krutzsch, H. C., Fiodart, J. M. and Stetler-Stevenson, W. G. (1995). Cell surface binding of TIMP-2 and proMMP-2/TIMP-2 complex, FEBS Lett, 364, 28.
   PubMed Web of Science ®Google Scholar
• Morgunova, E., Tuuttila, A., Bergmann, U., Isupov, M., Lindqvist, Y., Schneider, G. and Tryggvason, K. (1999). Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed, Science, 284, 1667.
   PubMed Web of Science ®Google Scholar
• Okada, A., Bellocq, J. P., Rouyer, N., Chenard, M. P., Rio, M. C., Chambon, P. and Basset, P. (1995). Membrane-type matrix metalloproteinases (MT-MMP) gene is expressed in stromal cells of human colon, breast and head and neck carcinomas, Proc Natl Acad Sci USA, 92, 2730.
   PubMed Web of Science ®Google Scholar
• Apte, S. S., Olsen, B. R. and Murphy, G. (1995). The gene structure of tissue inhibitor of metalloproteinase (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family, J Biol Chem, 270, 14313.
   PubMed Web of Science ®Google Scholar
• Greene, J., Wang, M., Liu, Y. E., Raymond, L. A., Rosen, C. and Shi, Y. E. (1996). Molecular cloning and characterization of human tissue inhibitor of metalloproteinase-4, J Biol Chem, 271, 30375.
   PubMed Web of Science ®Google Scholar
• Hayakawa, T. (1994). Tissue inhibitors of metalloproteinases and their cell-growth-promoting activity, Cell Struct Funct, 19, 109.
   PubMed Web of Science ®Google Scholar
• Avalos, B. R., Kaufman, S. E., Tomonaga, M., Williams, R. E., Golde, D. W. and Gasson, J. C. (1988). K562 cells produce and respond to human erythroid-potentiating activity, Blood, 71, 1720.
   PubMed Web of Science ®Google Scholar
• Stetler-Stevenson, W. G., Bersch, N. and Golde, D. W. (1992). Tissue inhibitor of metalloproteinase-2 (TIMP-2) has erythroid-potentiating activity, FEBS Letters, 296, 231.
   PubMed Web of Science ®Google Scholar
• Hayakawa, T., Yamashita, K., Tanzawa, K., Uchijima, E. and Iwata, K. (1992). Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells, FEBS Letters, 298, 29.
   PubMed Web of Science ®Google Scholar
• Edwards, D. R., Beaudry, P. P., Laing, T. D., Kowal, V., Leco, K. J., Leco, P. A. and Lim, M. S. (1996). The role of tissue inhibitors of metalloproteinases in tissue remodelling and cell growth, Int J Obesity, 20, 59.
   Web of Science ®Google Scholar
• Zaoui, P., Barro, C. and Morel, F. (1996). Differential expression and secretion of gelatinases and tissue inhibitor of metalloproteinase-1 during neutrophil adhesion, Biochim Biophys Acta, 1290, 101.
   PubMed Web of Science ®Google Scholar
• Leppert, D., Waubant, E., Galardy, R., Bunnett, N. W. and Hauser, S. L. (1995). T cell gelatinases mediate basement membrane transmigration in vitro, J Immunol, 154, 4379.
   PubMed Web of Science ®Google Scholar
• Shimizu, Y., Newman, W., Tanaka, Y. and Shaw, S. (1992). Lymphocyte interactions with endothelial cells, Immunol Today, 13, 106.
   PubMedGoogle Scholar
• Lauffenburger, D. A. and Horwitz, A. F. (1996). Cell migration: a physically integrated molecular process, Cell, 84, 359.
   PubMed Web of Science ®Google Scholar
• Kjeldsen, L., Bjerrum, O. W., Hovgaard, D., Johnsen, A. H., Sehested, M. and Borregaard, N. (1992). Human neutrophil gelatinase: a marker for circulating blood neutrophils. Purification and quantitation by enzyme-linked immunosorbent assay, Eur J Haematol, 49, 180.
   PubMed Web of Science ®Google Scholar
• Borregaard, N., Sehested, M., Nielsen, B. S., Sebgelov, H. and Kjeldsen, L. (1995). Biosynthesis of granule proteins in normal human bone marrow cells. Gelatinase is a marker of terminal neutrophil differentiation, Blood, 85, 812.
   PubMed Web of Science ®Google Scholar
• Hanlon, W. A., Stolk, J., Davies, P., Humes, J. L., Mumford, R. and Bonney, R. J. (1991). rTNF alpha facilitates human polymorphonuclear leukocyte adherence to fibrinogen matrices with mobilization of specific and tertiary but not azurophilic granule markers, J Leukocyte Biol, 50, 43.
   PubMed Web of Science ®Google Scholar
• Masure, S., Proost, P., Van Damme, J. and Opdenakker, G. (1991). Purification and identification of 91-kDa neutrophil gelatinase. Release by the activating peptide interleukin-8, Eur J Biochem, 198, 391.
   PubMedGoogle Scholar
• Welgus, H. G., Senior, R. M., Parks, W. C., Kahn, A. J., Ley, T. J., Shapiro, S. D. and Campbell, E. J. (1992). Neutral proteinase expression by human mononuclear phagocytes: a prominent role of cellular differentiation, Matrix Suppl, 1, 363.
   PubMedGoogle Scholar
• Opdenakker, G., Masure, S., Grillet, B. and Van Damme, J. (1991). Cytokine-mediated regulation of human leukocyte gelatinases and role in arthritis, Lymphokine and Cytokine Res, 10, 317.
   PubMedGoogle Scholar
• Wahl, S. M., Allen, J.B., Weeks, B. S., Wong, H. L. and Klotman, P. E. (1993). Transforming growth factor beta enhances integrin expression and type IV collagenase secretion in human monocytes, Proc Natl Acad Sci USA, 90, 4577.
   PubMed Web of Science ®Google Scholar
• Mertz, P. M., DeWitt, D. L., Stetler-Stevenson, W. G. and Wahl, L. M. (1994). Interleukin 10 suppression of monocyte prostaglandin H synthase-2. Mechanism of inhibition of prostaglandin-dependent matrix metalloproteinase production, J Biol Chem, 269, 21322.
   PubMed Web of Science ®Google Scholar
• Wahl, L. M. and Corcoran, M. L. (1993). Regulation of monocyte/macrophage metalloproteinase production by cytokines, J Periodontol, 64, 467.
   PubMed Web of Science ®Google Scholar
• Montgomery, A. M., Sabzevari, H. and Reisfeld, R. A. (1993). Production and regulation of gelatinase B by human T-cells, Biochim Biophys Acta, 1176, 265.
   PubMed Web of Science ®Google Scholar
• Xia, M., Leppert, D., Hauser, S. L., Sreedharan, S. P., Nelson, P. J., Krensky, A. M. and Goetzl, E. J. (1996). Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane, J Immunol, 156, 160.
   PubMed Web of Science ®Google Scholar
• Leppert, D., Hauser, S. L., Kishiyama, J. L., An, S., Zeng, L. and Goetzl, E. J. (1995). Stimulation of matrix metalloproteinase-dependent migration of T cells by eicosanoids, FASEB J, 9, 1473.
   PubMed Web of Science ®Google Scholar
• Johnatty, R. N., Taub, D. D., Reeder, S. P., TurcovskiCorrales, S. M., Cottam, D. W., Stephenson, T. J. and Rees, R. R. (1997). Cytokine and chemokine regulation of proMMP-9 and TIMP-1 production by human peripheral blood lymphocytes, J Immunol, 158, 2327.
   PubMed Web of Science ®Google Scholar
• Leppert, D., Waubant, E., Burk, M. R., Oksenberg, J. R. and Hauser, S. L. (1996). Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis, Annals Neurol, 40, 846.
   PubMed Web of Science ®Google Scholar
• Stuve, O., Dooley, N. P., Uhm, J. H., Antel, J. P., Francis, G. S., Williams, G. and Yong, V. W. (1996). Interferon β-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9, Annals Neurol, 40, 853.
   PubMed Web of Science ®Google Scholar
• Janowska-Wieczorek, A., Marquez, L. A., Nabholtz, J.-M., Cabuhat, M. L., Montañ;o, J., Chang, H., Rozmus, J., Russell, J. A., Edwards, D. R. and Turner, A. R. (1999). Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34+ cells and their transmigration through reconstituted basement membrane, Blood, 93, 3379.
   PubMed Web of Science ®Google Scholar
• Simmons, P. J., Leavesley, D. I., Levesque, J. P., Swart, B. W., Haylock, D. N., To, L. B., Ashman, L. K. and Juttner, C. A. (1994). The mobilization of primitive hematopoietic progenitors into the peripheral blood, in Murphy MJ (ed): Polyfunctionality of Hemopoietic Regulators: The Metcalf Forum, Stem Cells, 12 (Suppl 1), 187.
   Google Scholar
• Möhle, R., Moore, M. A. S., Nachman, R. L. and Rafii, S. (1997). Transendothelial migration of CD34+ and mature hematopoietic cells: an in vitro study using a human bone marrow endothelial cell line, Blood, 89, 72.
   PubMed Web of Science ®Google Scholar
• Papayannopoulou, T., Priestley, G. V. and Nakamoto, B. (1998). Anti-VLA4/VCAM-1-induced mobilization requires cooperative signalling through the kit/mkit ligand pathway, Blood, 91, 2231.
   PubMed Web of Science ®Google Scholar
• Brooks, P. C., Stromblad, S., Sanders, L. C., vonSchalscha, T. L., Aimes, R. T., Stetler-Stevenson, W. G., Quigley, J. P. and Cheresh, D. A. (1996). Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrins αvβ3, Cell, 85, 683.
   PubMed Web of Science ®Google Scholar
• Shimizu, Y., van Seventer, G. A., Horgan, K. J. and Shaw, S. (1990). Costimulation of proliferative responses of resting CD4+ T cells by the interaction of VLA-4 and VLA-5 with fibronectin or VLA-6 with laminin, J Immunol, 145, 59.
   PubMed Web of Science ®Google Scholar
• Romanic, A. M. and Madri, J. A. (1994). The induction of 72-kD gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent, J Cell Biol, 125, 1165.
   PubMed Web of Science ®Google Scholar
• Huhtala, P., Humphries, M. J., McCarthy, J. B., Tremble, P. M., Werb, Z. and Damsky, C. H. (1995). Cooperative signaling by α5β1 and α4β1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin, J Cell Biol, 129, 867.
   PubMed Web of Science ®Google Scholar
• Ray, J. M. and Stetler-Stevenson, W. G. (1995). Gelatinase A activity directly modulates melanoma cell adhesion and spreading, EMBO J, 14, 908.
   PubMed Web of Science ®Google Scholar
• Levesque, J. P., Leavesley, D. I., Niutta, S., Vardas, M. and Simmon, P. J. (1995). Cytokines increase human hematopoietic cell adhesiveness by activation of very late antigen (VLA)-4 and VLA-5 integrins, J Exp Med, 181, 1805.
   PubMed Web of Science ®Google Scholar
• Mayani, H., Guilbert, L., Sych, I. and Janowska-Wieczorek, A. (1992). Production of tumor necrosis factor-alpha in human long term marrow cultures from normal subjects and patients with acute myelogenous leukemia: effect of macrophage colony-stimulating factor, Leukemia, 6, 1148.
   PubMed Web of Science ®Google Scholar
• Gearing, A. J. H., Beckett, P., Christodoulou, M., Churchill, M., Clements, J., Davidson, A. H., Drummond, A. H., Galloway, W. A., Gilbert, R., Gordon, J. L., Leber, T. M., Mangan, M., Miller, K., Nayee, P., Owen, K., Pate, S., Thomas, W., Wells, G., Wood, L. M. and Woolley, K. (1994). Processing of tumour necrosis factor-α precursor by metalloproteinases, Nature, 370, 55.
   Web of Science ®Google Scholar
• McGeehan, G. M., Becherer, J. D., Vast, Jr., R. C., Boyer, C. M., Champion, B., Connolly, K. M., Conway, J. G., Furdon, P., Karp, S., Kidao, S., McElroy, A. B., Nichols, J., Pryzwansky, K. M., Schoenen, F., Sekut, L., Truesdale, A., Verghese, M., Warner, J. and Ways, J. P. (1994). Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor, Nature, 370, 558.
   PubMed Web of Science ®Google Scholar
• Crowe, P. D., Walter, B. N., Mohler, K. M., Otten-Evans, C., Black, R. A. and Ware, C. F. (1995). A metalloproteases inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes, J Exp Med, 181, 1205.
   PubMed Web of Science ®Google Scholar
• Suda, T., Takahashi, T., Golstein, P. and Nagata, S. (1993). Molecular cloning and expression of the Fas ligand: a novel member of the tumour necrosis factor family, Cell, 75, 1169.
   PubMed Web of Science ®Google Scholar
• Kayagaki, N., Kawasaki, A., Ebata, T., Ohmoto, H., Ikeda, S., Inoue, S., Yoshino, K., Okumura, K. and Yagita, H. (1995). Metalloproteinase-mediated release of human Fas ligand, J Exp Med, 182, 1777.
   PubMed Web of Science ®Google Scholar
• Hattari, K., Hirano, T., Ushiyama, C., Miyajima, H., Yamakawa, N., Ebata, T., Wada, Y., Ikeda, S., Yoshino, K., Tateno, M., Oshimi, K., Kayagaki, N., Yagita, H. and Okumura, K. (1997). A metalloproteinase inhibitor prevents lethal acute graft-versus-host disease in mice, Blood, 90, 542.
   PubMed Web of Science ®Google Scholar
• Tanaka, M., Suda, T., Haze, N., Nakamura, N., Sato, K., Kimura, F., Motoyoshi, K., Mizuki, M., Tagawa, S., Ohg, S., Hatake, K., Drummond, A. H. and Nagata, S. (1996). Fas ligand in human serum, Nature Med, 2, 317.
   PubMed Web of Science ®Google Scholar
• Cimino, G., Amadori, S., Cava, M. C., De Sanctics, V., Petti, M. C., Di Gregorio, A. O., Sgadari, C., Vegna, L., Cimino, G. and Mandelli, F. (1990). Serum interleukin-2 (IL-2), soluble IL-2 receptors and tumor necrosis factor-alpha levels are significantly increased in acute myelogenous leukemia patients, Leukemia, 5, 32.
   Web of Science ®Google Scholar
• Janiak, M., Hashmi, H. R. and Janowska-Wieczorek, A. (1994). Use of the Matrigel-based assay to measure the invasiveneness of leukemic cells, Exp Hematol, 22, 559.
   PubMed Web of Science ®Google Scholar
• Ray, J. M. and Stetler-Stevenson, W. G. (1994). The role of matrix metalloproteinases and their inhibitors in tumor invasion, metastasis and angiogenesis, Eur Respir J, 7, 2062.
   PubMed Web of Science ®Google Scholar
• Tryggvason, K., Hoyhtya, M. and Pyke, C. (1993). Type IV collagenases in invasive tumors, Breast Cancer Res Treat, 24, 209.
   PubMed Web of Science ®Google Scholar
• Goetzl, E. J., Banda, M. J. and Leppert, D. (1996). Matrix metalloproteinases in immunity, J Immunol, 156, 1.
   PubMed Web of Science ®Google Scholar
• Saren, P., Welgus, H. G. and Kovanen, P. T. (1996). TNF-α and IL-1β selectively induce expression of 92-kDa gelatinase by human macrophages, J Immunol, 157, 4159.
   PubMed Web of Science ®Google Scholar
• Adams, D. O. and Hamilton, P. A. (1987). Molecular transductional mechanisms by which IFN-gamma and other signals regulate macrophage development, Immunol Rev, 97, 5.
   PubMed Web of Science ®Google Scholar
• Lacraz, S., Nicod, L. P., Chicheportiche, R., Welgus, H. G. and Dayer, J.-M. (1995). IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes, J Clin Invest, 96, 2304.
   PubMed Web of Science ®Google Scholar
• Lacraz, S., Nicod, L. P., Galve-de Rochemonteix, B., Baumberger, C., Dayer, J.-M. and Welgus, H. G. (1992). Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4, J Clin Invest, 90, 382.
   PubMed Web of Science ®Google Scholar
• Shapiro, S. D., Kobayashi, D. K., Pentland, A. P. and Welgus, H. G. (1993). Induction of macrophage metalloproteinases by extracellular matrix, J Biol Chem, 268, 8170.
   PubMed Web of Science ®Google Scholar
• Corcoran, M. L., Kibbey, M. C., Kleinman, H. K. and Wahl, L. M. (1995). Laminin SIKVAV peptide induction of monocyte/macrophage prostaglandin E2 and matrix metalloproteinases, J Biol Chem, 270, 10365.
   PubMed Web of Science ®Google Scholar
• Miltenburg, A. M. M., Lacraz, S., Welgus, H. G. and Dayer, J.-M. (1995). Immobilized anti-CD3 antibody activates T cell clones to induce the production of interstitial collagenase, but not tissue inhibitor of metalloproteinases, in monocytic THP-1 cells and dermal fibroblasts, J Immunol, 154, 2655.
   PubMed Web of Science ®Google Scholar
• Salo, T., Makela, M., Kylmaniemi, M., Autio-Harmainen, H. and Larjava, H. (1994). Expression of matrix metalloproteinase-2 and -9 during early wound healing, Lab Invest, 70, 176.
   PubMed Web of Science ®Google Scholar
• Rawdanowicz, T. J., Hampton, A. L., Nagase, H., Woolley, D. E. and Salamonsen, L. A. (1994). Matrix metalloproteinases production by cultured human endometrial stromal cells: identification of interstitial collagenase, gelatinase-A, gelatinase-B and stromelysin-1 and their differential regulation by interleukin-1α and tumor necrosis factor-α, J Clin Endocrinol Met, 79, 530.
   PubMed Web of Science ®Google Scholar
• Rodgers, W. H., Matrisian, L. M., Giudice, L. L., Dsupin, B., Cannon, P., Svitek, C., Gorstein, F. and Osteen, K. G. (1994). Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones, J Clin Invest, 94, 946.
   PubMed Web of Science ®Google Scholar
• Rifas, L., Halstead, L. R., Peck, W. A., Avioli, L. V. and Welgus, H. G. (1989). Human osteoblasts in vitro secrete tissue inhibitor of metalloproteinases and gelatinase but not interstitial collagenase as major cellular products, J Clin Invest, 84, 686.
   PubMed Web of Science ®Google Scholar
• Lyons, J. G., Birkedal-Hansen, B., Pierson, M. C., Whitelock, J. M. and Birkedal-Hansen, H. (1993). Interleukin-1 beta and transforming growth factor-alpha/epidermal growth factor induce expression of M(r) 95000 type IV collagenase/gelatinase and interstitial fibroblast-type collagenase by rat mucosal keratinocvtes, J Biol Chem, 268, 19143.
   PubMed Web of Science ®Google Scholar
• Kerr, L. D., Holt, J. T. and Matrisian, L. M. (1988). Growth factors regulate transin gene expression by c-fos-dependent and c-fos-independent pathways, Science, 242, 1424.
   PubMed Web of Science ®Google Scholar
• Edwards, D. R., Murphy, G., Reynolds, J. J., Whitham, S. E., Docherty, A. J., Angel, P. and Heath, J. K. (1987). Transforming growth factor beta modulates expression of collagenase and metalloproteinase inhibitor, EMBO J, 6, 1899.
   PubMed Web of Science ®Google Scholar
• Okada, Y., Morodomi, T., Enghild, J. J., Suzuki, K., Yasui, A., Nakanishi, I., Salvesen, G. and Nagase, H. (1990). Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties, Eur J Biochem, 194, 721.
   PubMedGoogle Scholar
• Barillé, S., Akhoundi, C., Collette, M., Mellerin, M.-P., Rapp, M.-J., Harousseau, J.-L., Bataille, R. and Amiot, M. (1997). Metalloproteinases in multiple myeloma: production of matrix metalloproteinase-9 (MMP-9), activation of proMMP-2, and induction of MMP-1 by myeloma cells, Blood, 90, 1649.
   PubMed Web of Science ®Google Scholar